ARCHIVES

In Brief: Berlin Leaving Northwestern To Become Zubrod’s Deputy at Miami; Four Center Director Jobs Open

This article is from The Cancer Letter archive.

Vol. 13 No. 32 | August 7, 1987

Download PDF Visit The Full Archive

Related Articles

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

July 27, 2012

NSABP Sees Groups To Join Breast Cancer Prevention Trial

September 27, 1991

Anil Potti Reprimanded by North Carolina Licensure Board

December 9, 2011

In Brief: Senate Subcommittee Vote: $950 Million Plus training DeVita Needs New Clinical Assistant

July 21, 1978

NCI Suggests 75 Topics for SBIR Proposals

October 4, 1985

Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction.

April 21, 2006